nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—CYP3A4—prostate cancer	0.189	1	CbGaD
Estazolam—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0663	0.207	CbGbCtD
Estazolam—CYP3A4—Bicalutamide—prostate cancer	0.0348	0.109	CbGbCtD
Estazolam—CYP3A4—Estramustine—prostate cancer	0.0324	0.101	CbGbCtD
Estazolam—CYP3A4—Flutamide—prostate cancer	0.0288	0.09	CbGbCtD
Estazolam—CYP3A4—Abiraterone—prostate cancer	0.0288	0.09	CbGbCtD
Estazolam—CYP3A4—Cabazitaxel—prostate cancer	0.0213	0.0666	CbGbCtD
Estazolam—CYP3A4—Estrone—prostate cancer	0.0209	0.065	CbGbCtD
Estazolam—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0186	0.058	CbGbCtD
Estazolam—CYP3A4—Conjugated Estrogens—prostate cancer	0.0136	0.0426	CbGbCtD
Estazolam—CYP3A4—Mitoxantrone—prostate cancer	0.0124	0.0387	CbGbCtD
Estazolam—CYP3A4—Estradiol—prostate cancer	0.012	0.0374	CbGbCtD
Estazolam—CYP3A4—Prednisone—prostate cancer	0.0103	0.0321	CbGbCtD
Estazolam—CYP3A4—Etoposide—prostate cancer	0.00782	0.0244	CbGbCtD
Estazolam—CYP3A4—Docetaxel—prostate cancer	0.00716	0.0223	CbGbCtD
Estazolam—CYP3A4—Doxorubicin—prostate cancer	0.00533	0.0166	CbGbCtD
Estazolam—Lorazepam—UGT2B15—prostate cancer	0.00151	0.169	CrCbGaD
Estazolam—Oxazepam—UGT2B15—prostate cancer	0.000795	0.0885	CrCbGaD
Estazolam—Oxazepam—CYP3A43—prostate cancer	0.000689	0.0767	CrCbGaD
Estazolam—Clonazepam—NAT2—prostate cancer	0.000661	0.0736	CrCbGaD
Estazolam—GABRP—prostate gland—prostate cancer	0.000585	0.0996	CbGeAlD
Estazolam—CYP3A4—urine—prostate cancer	0.00054	0.0919	CbGeAlD
Estazolam—GABRE—prostate gland—prostate cancer	0.000447	0.076	CbGeAlD
Estazolam—GABRP—urethra—prostate cancer	0.000392	0.0667	CbGeAlD
Estazolam—GABRB3—prostate gland—prostate cancer	0.000379	0.0644	CbGeAlD
Estazolam—GABRE—seminal vesicle—prostate cancer	0.000378	0.0643	CbGeAlD
Estazolam—GABRG3—testis—prostate cancer	0.000372	0.0634	CbGeAlD
Estazolam—Clobazam—CYP2C18—prostate cancer	0.000368	0.041	CrCbGaD
Estazolam—GABRR1—testis—prostate cancer	0.000355	0.0604	CbGeAlD
Estazolam—GABRD—testis—prostate cancer	0.000308	0.0525	CbGeAlD
Estazolam—GABRE—urethra—prostate cancer	0.000299	0.0509	CbGeAlD
Estazolam—GABRA5—testis—prostate cancer	0.000286	0.0487	CbGeAlD
Estazolam—GABRR2—lymph node—prostate cancer	0.000267	0.0455	CbGeAlD
Estazolam—GABRA3—testis—prostate cancer	0.000266	0.0454	CbGeAlD
Estazolam—Alprazolam—CYP3A5—prostate cancer	0.000243	0.027	CrCbGaD
Estazolam—GABRB2—testis—prostate cancer	0.000217	0.037	CbGeAlD
Estazolam—Diazepam—CYP2C18—prostate cancer	0.000215	0.0239	CrCbGaD
Estazolam—Flunitrazepam—CYP2A6—prostate cancer	0.000215	0.0239	CrCbGaD
Estazolam—Midazolam—SLC22A1—prostate cancer	0.000205	0.0228	CrCbGaD
Estazolam—GABRE—testis—prostate cancer	0.000197	0.0335	CbGeAlD
Estazolam—Clonazepam—CYP2E1—prostate cancer	0.00019	0.0212	CrCbGaD
Estazolam—Triazolam—CYP3A5—prostate cancer	0.000178	0.0198	CrCbGaD
Estazolam—Oxazepam—CYP3A5—prostate cancer	0.000173	0.0192	CrCbGaD
Estazolam—Flurazepam—CYP2A6—prostate cancer	0.000173	0.0192	CrCbGaD
Estazolam—GABRB3—testis—prostate cancer	0.000167	0.0284	CbGeAlD
Estazolam—Midazolam—CYP3A5—prostate cancer	0.000165	0.0184	CrCbGaD
Estazolam—Clobazam—CYP2C19—prostate cancer	0.000165	0.0184	CrCbGaD
Estazolam—Quazepam—CYP2C19—prostate cancer	0.00016	0.0178	CrCbGaD
Estazolam—Flunitrazepam—CYP2E1—prostate cancer	0.000153	0.017	CrCbGaD
Estazolam—Flunitrazepam—CYP2C19—prostate cancer	0.000151	0.0168	CrCbGaD
Estazolam—Ketazolam—CYP3A4—prostate cancer	0.000149	0.0165	CrCbGaD
Estazolam—GABRA2—lymph node—prostate cancer	0.000144	0.0245	CbGeAlD
Estazolam—GABRE—lymph node—prostate cancer	0.000143	0.0243	CbGeAlD
Estazolam—Diazepam—CYP3A5—prostate cancer	0.000142	0.0158	CrCbGaD
Estazolam—Palpitations—Capecitabine—prostate cancer	0.000139	0.000353	CcSEcCtD
Estazolam—Decreased appetite—Etoposide—prostate cancer	0.000138	0.000352	CcSEcCtD
Estazolam—Arthralgia—Docetaxel—prostate cancer	0.000138	0.000351	CcSEcCtD
Estazolam—Myalgia—Docetaxel—prostate cancer	0.000138	0.000351	CcSEcCtD
Estazolam—Chest pain—Docetaxel—prostate cancer	0.000138	0.000351	CcSEcCtD
Estazolam—Loss of consciousness—Capecitabine—prostate cancer	0.000138	0.000351	CcSEcCtD
Estazolam—Nitrazepam—CYP2E1—prostate cancer	0.000138	0.0153	CrCbGaD
Estazolam—Asthenia—Mitoxantrone—prostate cancer	0.000137	0.00035	CcSEcCtD
Estazolam—Neuropathy peripheral—Epirubicin—prostate cancer	0.000137	0.000349	CcSEcCtD
Estazolam—Cough—Capecitabine—prostate cancer	0.000137	0.000349	CcSEcCtD
Estazolam—Constipation—Etoposide—prostate cancer	0.000136	0.000347	CcSEcCtD
Estazolam—Pain—Etoposide—prostate cancer	0.000136	0.000347	CcSEcCtD
Estazolam—Dizziness—Estradiol—prostate cancer	0.000136	0.000346	CcSEcCtD
Estazolam—Dry mouth—Docetaxel—prostate cancer	0.000135	0.000344	CcSEcCtD
Estazolam—Adinazolam—CYP2C19—prostate cancer	0.000135	0.015	CrCbGaD
Estazolam—Sweating—Epirubicin—prostate cancer	0.000134	0.000341	CcSEcCtD
Estazolam—Pollakiuria—Doxorubicin—prostate cancer	0.000134	0.000341	CcSEcCtD
Estazolam—Chest pain—Capecitabine—prostate cancer	0.000134	0.00034	CcSEcCtD
Estazolam—Myalgia—Capecitabine—prostate cancer	0.000134	0.00034	CcSEcCtD
Estazolam—Arthralgia—Capecitabine—prostate cancer	0.000134	0.00034	CcSEcCtD
Estazolam—Haematuria—Epirubicin—prostate cancer	0.000133	0.00034	CcSEcCtD
Estazolam—Confusional state—Docetaxel—prostate cancer	0.000133	0.00034	CcSEcCtD
Estazolam—Anxiety—Capecitabine—prostate cancer	0.000133	0.000339	CcSEcCtD
Estazolam—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000132	0.000337	CcSEcCtD
Estazolam—Oedema—Docetaxel—prostate cancer	0.000132	0.000337	CcSEcCtD
Estazolam—CYP3A4—renal system—prostate cancer	0.000132	0.0225	CbGeAlD
Estazolam—Weight increased—Doxorubicin—prostate cancer	0.000132	0.000336	CcSEcCtD
Estazolam—Discomfort—Capecitabine—prostate cancer	0.000132	0.000336	CcSEcCtD
Estazolam—Epistaxis—Epirubicin—prostate cancer	0.000132	0.000336	CcSEcCtD
Estazolam—Weight decreased—Doxorubicin—prostate cancer	0.000131	0.000334	CcSEcCtD
Estazolam—Sinusitis—Epirubicin—prostate cancer	0.000131	0.000334	CcSEcCtD
Estazolam—Feeling abnormal—Etoposide—prostate cancer	0.000131	0.000334	CcSEcCtD
Estazolam—Dry mouth—Capecitabine—prostate cancer	0.000131	0.000333	CcSEcCtD
Estazolam—Vomiting—Estradiol—prostate cancer	0.00013	0.000332	CcSEcCtD
Estazolam—Agranulocytosis—Epirubicin—prostate cancer	0.00013	0.000332	CcSEcCtD
Estazolam—Gastrointestinal pain—Etoposide—prostate cancer	0.00013	0.000331	CcSEcCtD
Estazolam—Shock—Docetaxel—prostate cancer	0.00013	0.000331	CcSEcCtD
Estazolam—Ill-defined disorder—Prednisone—prostate cancer	0.00013	0.00033	CcSEcCtD
Estazolam—Rash—Estradiol—prostate cancer	0.000129	0.00033	CcSEcCtD
Estazolam—Dermatitis—Estradiol—prostate cancer	0.000129	0.000329	CcSEcCtD
Estazolam—Confusional state—Capecitabine—prostate cancer	0.000129	0.000329	CcSEcCtD
Estazolam—Headache—Estradiol—prostate cancer	0.000129	0.000328	CcSEcCtD
Estazolam—Agitation—Prednisone—prostate cancer	0.000128	0.000327	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000128	0.000327	CcSEcCtD
Estazolam—Oedema—Capecitabine—prostate cancer	0.000128	0.000326	CcSEcCtD
Estazolam—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000127	0.000323	CcSEcCtD
Estazolam—Urticaria—Etoposide—prostate cancer	0.000126	0.000322	CcSEcCtD
Estazolam—Malaise—Prednisone—prostate cancer	0.000126	0.000321	CcSEcCtD
Estazolam—Shock—Capecitabine—prostate cancer	0.000126	0.000321	CcSEcCtD
Estazolam—Rhinitis—Epirubicin—prostate cancer	0.000126	0.000321	CcSEcCtD
Estazolam—Abdominal pain—Etoposide—prostate cancer	0.000126	0.00032	CcSEcCtD
Estazolam—Body temperature increased—Etoposide—prostate cancer	0.000126	0.00032	CcSEcCtD
Estazolam—Syncope—Prednisone—prostate cancer	0.000125	0.000319	CcSEcCtD
Estazolam—Pharyngitis—Epirubicin—prostate cancer	0.000125	0.000317	CcSEcCtD
Estazolam—Sweating—Doxorubicin—prostate cancer	0.000124	0.000316	CcSEcCtD
Estazolam—Chlordiazepoxide—CYP3A4—prostate cancer	0.000124	0.0138	CrCbGaD
Estazolam—Hyperhidrosis—Capecitabine—prostate cancer	0.000124	0.000315	CcSEcCtD
Estazolam—Haematuria—Doxorubicin—prostate cancer	0.000123	0.000314	CcSEcCtD
Estazolam—Loss of consciousness—Prednisone—prostate cancer	0.000123	0.000313	CcSEcCtD
Estazolam—Flurazepam—CYP2E1—prostate cancer	0.000123	0.0136	CrCbGaD
Estazolam—Epistaxis—Doxorubicin—prostate cancer	0.000122	0.000311	CcSEcCtD
Estazolam—Nausea—Estradiol—prostate cancer	0.000122	0.000311	CcSEcCtD
Estazolam—Vomiting—Mitoxantrone—prostate cancer	0.000122	0.00031	CcSEcCtD
Estazolam—Sinusitis—Doxorubicin—prostate cancer	0.000121	0.000309	CcSEcCtD
Estazolam—Convulsion—Prednisone—prostate cancer	0.000121	0.000308	CcSEcCtD
Estazolam—Visual impairment—Epirubicin—prostate cancer	0.000121	0.000308	CcSEcCtD
Estazolam—Agranulocytosis—Doxorubicin—prostate cancer	0.000121	0.000308	CcSEcCtD
Estazolam—Rash—Mitoxantrone—prostate cancer	0.000121	0.000307	CcSEcCtD
Estazolam—Dermatitis—Mitoxantrone—prostate cancer	0.00012	0.000307	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.00012	0.000307	CcSEcCtD
Estazolam—Headache—Mitoxantrone—prostate cancer	0.00012	0.000305	CcSEcCtD
Estazolam—Clonazepam—CYP3A4—prostate cancer	0.00012	0.0133	CrCbGaD
Estazolam—Myalgia—Prednisone—prostate cancer	0.000119	0.000303	CcSEcCtD
Estazolam—Arthralgia—Prednisone—prostate cancer	0.000119	0.000303	CcSEcCtD
Estazolam—Paraesthesia—Docetaxel—prostate cancer	0.000119	0.000302	CcSEcCtD
Estazolam—Erythema multiforme—Epirubicin—prostate cancer	0.000119	0.000302	CcSEcCtD
Estazolam—Anxiety—Prednisone—prostate cancer	0.000119	0.000302	CcSEcCtD
Estazolam—Dyspnoea—Docetaxel—prostate cancer	0.000118	0.0003	CcSEcCtD
Estazolam—Somnolence—Docetaxel—prostate cancer	0.000118	0.000299	CcSEcCtD
Estazolam—Discomfort—Prednisone—prostate cancer	0.000117	0.000299	CcSEcCtD
Estazolam—Hypersensitivity—Etoposide—prostate cancer	0.000117	0.000299	CcSEcCtD
Estazolam—Tinnitus—Epirubicin—prostate cancer	0.000117	0.000298	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000117	0.000297	CcSEcCtD
Estazolam—Flushing—Epirubicin—prostate cancer	0.000116	0.000297	CcSEcCtD
Estazolam—Rhinitis—Doxorubicin—prostate cancer	0.000116	0.000297	CcSEcCtD
Estazolam—Dyspepsia—Docetaxel—prostate cancer	0.000116	0.000296	CcSEcCtD
Estazolam—Temazepam—CYP2C19—prostate cancer	0.000116	0.0129	CrCbGaD
Estazolam—Clorazepate—CYP3A4—prostate cancer	0.000116	0.0129	CrCbGaD
Estazolam—Pharyngitis—Doxorubicin—prostate cancer	0.000115	0.000294	CcSEcCtD
Estazolam—Paraesthesia—Capecitabine—prostate cancer	0.000115	0.000293	CcSEcCtD
Estazolam—Decreased appetite—Docetaxel—prostate cancer	0.000115	0.000293	CcSEcCtD
Estazolam—Asthenia—Etoposide—prostate cancer	0.000114	0.000291	CcSEcCtD
Estazolam—Dyspnoea—Capecitabine—prostate cancer	0.000114	0.000291	CcSEcCtD
Estazolam—Oedema—Prednisone—prostate cancer	0.000114	0.00029	CcSEcCtD
Estazolam—Midazolam—CYP2E1—prostate cancer	0.000114	0.0127	CrCbGaD
Estazolam—Nausea—Mitoxantrone—prostate cancer	0.000114	0.000289	CcSEcCtD
Estazolam—Constipation—Docetaxel—prostate cancer	0.000113	0.000288	CcSEcCtD
Estazolam—Pain—Docetaxel—prostate cancer	0.000113	0.000288	CcSEcCtD
Estazolam—Dyspepsia—Capecitabine—prostate cancer	0.000113	0.000287	CcSEcCtD
Estazolam—Chills—Epirubicin—prostate cancer	0.000113	0.000287	CcSEcCtD
Estazolam—Pruritus—Etoposide—prostate cancer	0.000113	0.000287	CcSEcCtD
Estazolam—Shock—Prednisone—prostate cancer	0.000112	0.000286	CcSEcCtD
Estazolam—Arrhythmia—Epirubicin—prostate cancer	0.000112	0.000286	CcSEcCtD
Estazolam—Visual impairment—Doxorubicin—prostate cancer	0.000112	0.000285	CcSEcCtD
Estazolam—Decreased appetite—Capecitabine—prostate cancer	0.000111	0.000283	CcSEcCtD
Estazolam—Hyperhidrosis—Prednisone—prostate cancer	0.00011	0.000281	CcSEcCtD
Estazolam—Erythema multiforme—Doxorubicin—prostate cancer	0.00011	0.00028	CcSEcCtD
Estazolam—Constipation—Capecitabine—prostate cancer	0.000109	0.000279	CcSEcCtD
Estazolam—Pain—Capecitabine—prostate cancer	0.000109	0.000279	CcSEcCtD
Estazolam—Malnutrition—Epirubicin—prostate cancer	0.000109	0.000278	CcSEcCtD
Estazolam—Feeling abnormal—Docetaxel—prostate cancer	0.000109	0.000278	CcSEcCtD
Estazolam—Tinnitus—Doxorubicin—prostate cancer	0.000108	0.000276	CcSEcCtD
Estazolam—Gastrointestinal pain—Docetaxel—prostate cancer	0.000108	0.000275	CcSEcCtD
Estazolam—Flushing—Doxorubicin—prostate cancer	0.000108	0.000275	CcSEcCtD
Estazolam—Flatulence—Epirubicin—prostate cancer	0.000108	0.000274	CcSEcCtD
Estazolam—Tension—Epirubicin—prostate cancer	0.000107	0.000273	CcSEcCtD
Estazolam—Nervousness—Epirubicin—prostate cancer	0.000106	0.00027	CcSEcCtD
Estazolam—Back pain—Epirubicin—prostate cancer	0.000106	0.000269	CcSEcCtD
Estazolam—Feeling abnormal—Capecitabine—prostate cancer	0.000105	0.000269	CcSEcCtD
Estazolam—Dizziness—Etoposide—prostate cancer	0.000105	0.000268	CcSEcCtD
Estazolam—Muscle spasms—Epirubicin—prostate cancer	0.000105	0.000268	CcSEcCtD
Estazolam—Clobazam—CYP3A4—prostate cancer	0.000105	0.0117	CrCbGaD
Estazolam—Alprazolam—CYP3A4—prostate cancer	0.000105	0.0117	CrCbGaD
Estazolam—Gastrointestinal pain—Capecitabine—prostate cancer	0.000105	0.000267	CcSEcCtD
Estazolam—Body temperature increased—Docetaxel—prostate cancer	0.000104	0.000266	CcSEcCtD
Estazolam—Abdominal pain—Docetaxel—prostate cancer	0.000104	0.000266	CcSEcCtD
Estazolam—Chills—Doxorubicin—prostate cancer	0.000104	0.000265	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000104	0.000265	CcSEcCtD
Estazolam—Arrhythmia—Doxorubicin—prostate cancer	0.000104	0.000264	CcSEcCtD
Estazolam—Paraesthesia—Prednisone—prostate cancer	0.000102	0.000261	CcSEcCtD
Estazolam—Quazepam—CYP3A4—prostate cancer	0.000102	0.0113	CrCbGaD
Estazolam—Urticaria—Capecitabine—prostate cancer	0.000102	0.000259	CcSEcCtD
Estazolam—Ill-defined disorder—Epirubicin—prostate cancer	0.000101	0.000258	CcSEcCtD
Estazolam—Body temperature increased—Capecitabine—prostate cancer	0.000101	0.000258	CcSEcCtD
Estazolam—Abdominal pain—Capecitabine—prostate cancer	0.000101	0.000258	CcSEcCtD
Estazolam—Vomiting—Etoposide—prostate cancer	0.000101	0.000258	CcSEcCtD
Estazolam—Malnutrition—Doxorubicin—prostate cancer	0.000101	0.000258	CcSEcCtD
Estazolam—Agitation—Epirubicin—prostate cancer	0.0001	0.000256	CcSEcCtD
Estazolam—Dyspepsia—Prednisone—prostate cancer	0.0001	0.000256	CcSEcCtD
Estazolam—Rash—Etoposide—prostate cancer	0.0001	0.000256	CcSEcCtD
Estazolam—Dermatitis—Etoposide—prostate cancer	0.0001	0.000255	CcSEcCtD
Estazolam—Headache—Etoposide—prostate cancer	9.96e-05	0.000254	CcSEcCtD
Estazolam—Flatulence—Doxorubicin—prostate cancer	9.96e-05	0.000254	CcSEcCtD
Estazolam—Tension—Doxorubicin—prostate cancer	9.92e-05	0.000253	CcSEcCtD
Estazolam—Decreased appetite—Prednisone—prostate cancer	9.91e-05	0.000252	CcSEcCtD
Estazolam—Malaise—Epirubicin—prostate cancer	9.85e-05	0.000251	CcSEcCtD
Estazolam—Nervousness—Doxorubicin—prostate cancer	9.82e-05	0.00025	CcSEcCtD
Estazolam—Syncope—Epirubicin—prostate cancer	9.8e-05	0.00025	CcSEcCtD
Estazolam—Leukopenia—Epirubicin—prostate cancer	9.78e-05	0.000249	CcSEcCtD
Estazolam—Back pain—Doxorubicin—prostate cancer	9.78e-05	0.000249	CcSEcCtD
Estazolam—Constipation—Prednisone—prostate cancer	9.75e-05	0.000248	CcSEcCtD
Estazolam—Hypersensitivity—Docetaxel—prostate cancer	9.74e-05	0.000248	CcSEcCtD
Estazolam—Diazepam—CYP2E1—prostate cancer	9.73e-05	0.0108	CrCbGaD
Estazolam—Muscle spasms—Doxorubicin—prostate cancer	9.72e-05	0.000248	CcSEcCtD
Estazolam—Palpitations—Epirubicin—prostate cancer	9.65e-05	0.000246	CcSEcCtD
Estazolam—Diazepam—CYP2C19—prostate cancer	9.64e-05	0.0107	CrCbGaD
Estazolam—Flunitrazepam—CYP3A4—prostate cancer	9.61e-05	0.0107	CrCbGaD
Estazolam—Loss of consciousness—Epirubicin—prostate cancer	9.6e-05	0.000245	CcSEcCtD
Estazolam—Cough—Epirubicin—prostate cancer	9.53e-05	0.000243	CcSEcCtD
Estazolam—Asthenia—Docetaxel—prostate cancer	9.48e-05	0.000242	CcSEcCtD
Estazolam—Convulsion—Epirubicin—prostate cancer	9.47e-05	0.000241	CcSEcCtD
Estazolam—Nausea—Etoposide—prostate cancer	9.45e-05	0.000241	CcSEcCtD
Estazolam—Hypersensitivity—Capecitabine—prostate cancer	9.43e-05	0.00024	CcSEcCtD
Estazolam—Feeling abnormal—Prednisone—prostate cancer	9.39e-05	0.000239	CcSEcCtD
Estazolam—Ill-defined disorder—Doxorubicin—prostate cancer	9.38e-05	0.000239	CcSEcCtD
Estazolam—Pruritus—Docetaxel—prostate cancer	9.35e-05	0.000238	CcSEcCtD
Estazolam—Gastrointestinal pain—Prednisone—prostate cancer	9.32e-05	0.000238	CcSEcCtD
Estazolam—Chest pain—Epirubicin—prostate cancer	9.3e-05	0.000237	CcSEcCtD
Estazolam—Arthralgia—Epirubicin—prostate cancer	9.3e-05	0.000237	CcSEcCtD
Estazolam—Myalgia—Epirubicin—prostate cancer	9.3e-05	0.000237	CcSEcCtD
Estazolam—Agitation—Doxorubicin—prostate cancer	9.29e-05	0.000237	CcSEcCtD
Estazolam—Anxiety—Epirubicin—prostate cancer	9.27e-05	0.000236	CcSEcCtD
Estazolam—Discomfort—Epirubicin—prostate cancer	9.19e-05	0.000234	CcSEcCtD
Estazolam—Asthenia—Capecitabine—prostate cancer	9.18e-05	0.000234	CcSEcCtD
Estazolam—Malaise—Doxorubicin—prostate cancer	9.12e-05	0.000232	CcSEcCtD
Estazolam—Dry mouth—Epirubicin—prostate cancer	9.1e-05	0.000232	CcSEcCtD
Estazolam—Syncope—Doxorubicin—prostate cancer	9.06e-05	0.000231	CcSEcCtD
Estazolam—Urticaria—Prednisone—prostate cancer	9.06e-05	0.000231	CcSEcCtD
Estazolam—Pruritus—Capecitabine—prostate cancer	9.05e-05	0.000231	CcSEcCtD
Estazolam—Leukopenia—Doxorubicin—prostate cancer	9.05e-05	0.000231	CcSEcCtD
Estazolam—Abdominal pain—Prednisone—prostate cancer	9.01e-05	0.00023	CcSEcCtD
Estazolam—Body temperature increased—Prednisone—prostate cancer	9.01e-05	0.00023	CcSEcCtD
Estazolam—Confusional state—Epirubicin—prostate cancer	8.99e-05	0.000229	CcSEcCtD
Estazolam—Palpitations—Doxorubicin—prostate cancer	8.93e-05	0.000228	CcSEcCtD
Estazolam—Oedema—Epirubicin—prostate cancer	8.92e-05	0.000227	CcSEcCtD
Estazolam—Loss of consciousness—Doxorubicin—prostate cancer	8.88e-05	0.000226	CcSEcCtD
Estazolam—Cough—Doxorubicin—prostate cancer	8.82e-05	0.000225	CcSEcCtD
Estazolam—Shock—Epirubicin—prostate cancer	8.77e-05	0.000223	CcSEcCtD
Estazolam—Convulsion—Doxorubicin—prostate cancer	8.76e-05	0.000223	CcSEcCtD
Estazolam—Dizziness—Docetaxel—prostate cancer	8.74e-05	0.000223	CcSEcCtD
Estazolam—Nitrazepam—CYP3A4—prostate cancer	8.68e-05	0.00967	CrCbGaD
Estazolam—Hyperhidrosis—Epirubicin—prostate cancer	8.62e-05	0.00022	CcSEcCtD
Estazolam—Myalgia—Doxorubicin—prostate cancer	8.61e-05	0.000219	CcSEcCtD
Estazolam—Chest pain—Doxorubicin—prostate cancer	8.61e-05	0.000219	CcSEcCtD
Estazolam—Arthralgia—Doxorubicin—prostate cancer	8.61e-05	0.000219	CcSEcCtD
Estazolam—Anxiety—Doxorubicin—prostate cancer	8.58e-05	0.000219	CcSEcCtD
Estazolam—Adinazolam—CYP3A4—prostate cancer	8.56e-05	0.00953	CrCbGaD
Estazolam—Discomfort—Doxorubicin—prostate cancer	8.5e-05	0.000217	CcSEcCtD
Estazolam—Dizziness—Capecitabine—prostate cancer	8.46e-05	0.000216	CcSEcCtD
Estazolam—Dry mouth—Doxorubicin—prostate cancer	8.42e-05	0.000214	CcSEcCtD
Estazolam—Vomiting—Docetaxel—prostate cancer	8.4e-05	0.000214	CcSEcCtD
Estazolam—Hypersensitivity—Prednisone—prostate cancer	8.4e-05	0.000214	CcSEcCtD
Estazolam—Rash—Docetaxel—prostate cancer	8.33e-05	0.000212	CcSEcCtD
Estazolam—Dermatitis—Docetaxel—prostate cancer	8.33e-05	0.000212	CcSEcCtD
Estazolam—Confusional state—Doxorubicin—prostate cancer	8.32e-05	0.000212	CcSEcCtD
Estazolam—Headache—Docetaxel—prostate cancer	8.28e-05	0.000211	CcSEcCtD
Estazolam—Prazepam—CYP3A4—prostate cancer	8.28e-05	0.00922	CrCbGaD
Estazolam—Oedema—Doxorubicin—prostate cancer	8.25e-05	0.00021	CcSEcCtD
Estazolam—Asthenia—Prednisone—prostate cancer	8.18e-05	0.000208	CcSEcCtD
Estazolam—Vomiting—Capecitabine—prostate cancer	8.14e-05	0.000207	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Epirubicin—prostate cancer	8.12e-05	0.000207	CcSEcCtD
Estazolam—Shock—Doxorubicin—prostate cancer	8.12e-05	0.000207	CcSEcCtD
Estazolam—Rash—Capecitabine—prostate cancer	8.07e-05	0.000206	CcSEcCtD
Estazolam—Pruritus—Prednisone—prostate cancer	8.07e-05	0.000205	CcSEcCtD
Estazolam—Dermatitis—Capecitabine—prostate cancer	8.06e-05	0.000205	CcSEcCtD
Estazolam—Headache—Capecitabine—prostate cancer	8.02e-05	0.000204	CcSEcCtD
Estazolam—Paraesthesia—Epirubicin—prostate cancer	8.01e-05	0.000204	CcSEcCtD
Estazolam—Hyperhidrosis—Doxorubicin—prostate cancer	7.98e-05	0.000203	CcSEcCtD
Estazolam—Dyspnoea—Epirubicin—prostate cancer	7.95e-05	0.000203	CcSEcCtD
Estazolam—Somnolence—Epirubicin—prostate cancer	7.93e-05	0.000202	CcSEcCtD
Estazolam—Nausea—Docetaxel—prostate cancer	7.85e-05	0.0002	CcSEcCtD
Estazolam—Dyspepsia—Epirubicin—prostate cancer	7.85e-05	0.0002	CcSEcCtD
Estazolam—Decreased appetite—Epirubicin—prostate cancer	7.75e-05	0.000197	CcSEcCtD
Estazolam—Flurazepam—CYP3A4—prostate cancer	7.72e-05	0.00859	CrCbGaD
Estazolam—Triazolam—CYP3A4—prostate cancer	7.71e-05	0.00858	CrCbGaD
Estazolam—Constipation—Epirubicin—prostate cancer	7.62e-05	0.000194	CcSEcCtD
Estazolam—Pain—Epirubicin—prostate cancer	7.62e-05	0.000194	CcSEcCtD
Estazolam—Nausea—Capecitabine—prostate cancer	7.6e-05	0.000194	CcSEcCtD
Estazolam—Dizziness—Prednisone—prostate cancer	7.54e-05	0.000192	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.52e-05	0.000191	CcSEcCtD
Estazolam—Oxazepam—CYP3A4—prostate cancer	7.47e-05	0.00832	CrCbGaD
Estazolam—Paraesthesia—Doxorubicin—prostate cancer	7.41e-05	0.000189	CcSEcCtD
Estazolam—Temazepam—CYP3A4—prostate cancer	7.38e-05	0.00822	CrCbGaD
Estazolam—Dyspnoea—Doxorubicin—prostate cancer	7.35e-05	0.000187	CcSEcCtD
Estazolam—Feeling abnormal—Epirubicin—prostate cancer	7.35e-05	0.000187	CcSEcCtD
Estazolam—Somnolence—Doxorubicin—prostate cancer	7.33e-05	0.000187	CcSEcCtD
Estazolam—Gastrointestinal pain—Epirubicin—prostate cancer	7.29e-05	0.000186	CcSEcCtD
Estazolam—Dyspepsia—Doxorubicin—prostate cancer	7.26e-05	0.000185	CcSEcCtD
Estazolam—Vomiting—Prednisone—prostate cancer	7.25e-05	0.000185	CcSEcCtD
Estazolam—Rash—Prednisone—prostate cancer	7.19e-05	0.000183	CcSEcCtD
Estazolam—Dermatitis—Prednisone—prostate cancer	7.18e-05	0.000183	CcSEcCtD
Estazolam—Decreased appetite—Doxorubicin—prostate cancer	7.17e-05	0.000183	CcSEcCtD
Estazolam—Midazolam—CYP3A4—prostate cancer	7.15e-05	0.00797	CrCbGaD
Estazolam—Headache—Prednisone—prostate cancer	7.14e-05	0.000182	CcSEcCtD
Estazolam—Urticaria—Epirubicin—prostate cancer	7.08e-05	0.00018	CcSEcCtD
Estazolam—Pain—Doxorubicin—prostate cancer	7.05e-05	0.00018	CcSEcCtD
Estazolam—Constipation—Doxorubicin—prostate cancer	7.05e-05	0.00018	CcSEcCtD
Estazolam—Abdominal pain—Epirubicin—prostate cancer	7.05e-05	0.00018	CcSEcCtD
Estazolam—Body temperature increased—Epirubicin—prostate cancer	7.05e-05	0.00018	CcSEcCtD
Estazolam—Feeling abnormal—Doxorubicin—prostate cancer	6.8e-05	0.000173	CcSEcCtD
Estazolam—Nausea—Prednisone—prostate cancer	6.77e-05	0.000173	CcSEcCtD
Estazolam—Gastrointestinal pain—Doxorubicin—prostate cancer	6.75e-05	0.000172	CcSEcCtD
Estazolam—Hypersensitivity—Epirubicin—prostate cancer	6.57e-05	0.000167	CcSEcCtD
Estazolam—Urticaria—Doxorubicin—prostate cancer	6.55e-05	0.000167	CcSEcCtD
Estazolam—Body temperature increased—Doxorubicin—prostate cancer	6.52e-05	0.000166	CcSEcCtD
Estazolam—Abdominal pain—Doxorubicin—prostate cancer	6.52e-05	0.000166	CcSEcCtD
Estazolam—Asthenia—Epirubicin—prostate cancer	6.4e-05	0.000163	CcSEcCtD
Estazolam—Pruritus—Epirubicin—prostate cancer	6.31e-05	0.000161	CcSEcCtD
Estazolam—Diazepam—CYP3A4—prostate cancer	6.13e-05	0.00683	CrCbGaD
Estazolam—Hypersensitivity—Doxorubicin—prostate cancer	6.08e-05	0.000155	CcSEcCtD
Estazolam—Asthenia—Doxorubicin—prostate cancer	5.92e-05	0.000151	CcSEcCtD
Estazolam—Dizziness—Epirubicin—prostate cancer	5.9e-05	0.00015	CcSEcCtD
Estazolam—Pruritus—Doxorubicin—prostate cancer	5.84e-05	0.000149	CcSEcCtD
Estazolam—Vomiting—Epirubicin—prostate cancer	5.67e-05	0.000144	CcSEcCtD
Estazolam—Rash—Epirubicin—prostate cancer	5.62e-05	0.000143	CcSEcCtD
Estazolam—Dermatitis—Epirubicin—prostate cancer	5.62e-05	0.000143	CcSEcCtD
Estazolam—Headache—Epirubicin—prostate cancer	5.59e-05	0.000142	CcSEcCtD
Estazolam—Dizziness—Doxorubicin—prostate cancer	5.46e-05	0.000139	CcSEcCtD
Estazolam—Nausea—Epirubicin—prostate cancer	5.3e-05	0.000135	CcSEcCtD
Estazolam—Vomiting—Doxorubicin—prostate cancer	5.25e-05	0.000134	CcSEcCtD
Estazolam—Rash—Doxorubicin—prostate cancer	5.2e-05	0.000133	CcSEcCtD
Estazolam—Dermatitis—Doxorubicin—prostate cancer	5.2e-05	0.000132	CcSEcCtD
Estazolam—Headache—Doxorubicin—prostate cancer	5.17e-05	0.000132	CcSEcCtD
Estazolam—Nausea—Doxorubicin—prostate cancer	4.9e-05	0.000125	CcSEcCtD
Estazolam—GABRA1—Neuronal System—COMT—prostate cancer	4.69e-05	0.000564	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA3—prostate cancer	4.64e-05	0.000559	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—GNG5—prostate cancer	4.64e-05	0.000559	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.63e-05	0.000557	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	4.59e-05	0.000553	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	4.58e-05	0.000551	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.56e-05	0.000548	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—MDM2—prostate cancer	4.52e-05	0.000544	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CASP3—prostate cancer	4.43e-05	0.000534	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	4.38e-05	0.000527	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	4.35e-05	0.000524	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.33e-05	0.000521	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	4.32e-05	0.00052	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	4.29e-05	0.000517	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CTNNB1—prostate cancer	4.27e-05	0.000514	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	4.27e-05	0.000513	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	4.25e-05	0.000511	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA4—prostate cancer	4.25e-05	0.000511	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	4.24e-05	0.00051	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.2e-05	0.000506	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	4.19e-05	0.000504	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	4.17e-05	0.000501	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA2—prostate cancer	4.14e-05	0.000498	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.13e-05	0.000497	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—MDM2—prostate cancer	4.09e-05	0.000492	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	4.09e-05	0.000492	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.09e-05	0.000492	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.08e-05	0.000491	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—GNG5—prostate cancer	4.06e-05	0.000488	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.06e-05	0.000488	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	4.03e-05	0.000485	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.03e-05	0.000485	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.02e-05	0.000484	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA1—prostate cancer	3.99e-05	0.000481	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—MDM2—prostate cancer	3.97e-05	0.000478	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.96e-05	0.000477	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.96e-05	0.000476	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTO1—prostate cancer	3.95e-05	0.000475	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—NAT2—prostate cancer	3.95e-05	0.000475	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—MDM2—prostate cancer	3.9e-05	0.00047	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	3.89e-05	0.000469	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	3.89e-05	0.000469	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.89e-05	0.000469	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.89e-05	0.000469	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—RXRA—prostate cancer	3.89e-05	0.000468	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—SRC—prostate cancer	3.86e-05	0.000465	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—MDM2—prostate cancer	3.84e-05	0.000462	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—RXRA—prostate cancer	3.83e-05	0.000461	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.83e-05	0.00046	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—MDM2—prostate cancer	3.81e-05	0.000459	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.8e-05	0.000457	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	3.78e-05	0.000456	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.78e-05	0.000455	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.78e-05	0.000455	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—MDM2—prostate cancer	3.74e-05	0.00045	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	3.73e-05	0.000449	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.73e-05	0.000449	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	3.73e-05	0.000449	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—STAT3—prostate cancer	3.73e-05	0.000448	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—MDM2—prostate cancer	3.72e-05	0.000448	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.71e-05	0.000447	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—MDM2—prostate cancer	3.67e-05	0.000441	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.65e-05	0.000439	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.63e-05	0.000436	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—PPARA—prostate cancer	3.6e-05	0.000434	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—prostate cancer	3.57e-05	0.00043	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.56e-05	0.000429	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	3.52e-05	0.000423	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	3.48e-05	0.000419	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	3.47e-05	0.000418	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.46e-05	0.000416	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	3.44e-05	0.000414	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.44e-05	0.000414	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.34e-05	0.000402	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	3.31e-05	0.000398	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.28e-05	0.000395	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	3.28e-05	0.000394	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—RXRA—prostate cancer	3.27e-05	0.000394	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	3.27e-05	0.000394	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.26e-05	0.000393	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.22e-05	0.000388	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.2e-05	0.000385	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	3.2e-05	0.000385	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—RXRA—prostate cancer	3.18e-05	0.000382	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—HPGDS—prostate cancer	3.16e-05	0.00038	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.15e-05	0.000379	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	3.14e-05	0.000377	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—MDM2—prostate cancer	3.13e-05	0.000377	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—RXRA—prostate cancer	3.12e-05	0.000376	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.11e-05	0.000375	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	3.09e-05	0.000372	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—RXRA—prostate cancer	3.07e-05	0.000369	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTT1—prostate cancer	3.06e-05	0.000368	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—RXRA—prostate cancer	3.05e-05	0.000367	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—MDM2—prostate cancer	3.05e-05	0.000366	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	3.03e-05	0.000365	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	3.03e-05	0.000364	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3e-05	0.000361	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.99e-05	0.00036	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—MDM2—prostate cancer	2.99e-05	0.00036	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—PPARA—prostate cancer	2.97e-05	0.000357	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—MDM2—prostate cancer	2.94e-05	0.000354	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.92e-05	0.000352	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—MDM2—prostate cancer	2.92e-05	0.000351	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	2.9e-05	0.000349	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	2.9e-05	0.000349	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—MDM2—prostate cancer	2.87e-05	0.000345	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.86e-05	0.000344	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	2.86e-05	0.000344	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—NCOA2—prostate cancer	2.76e-05	0.000332	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.75e-05	0.000331	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	2.61e-05	0.000315	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	2.57e-05	0.00031	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	2.54e-05	0.000305	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—MDM2—prostate cancer	2.51e-05	0.000302	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.5e-05	0.000301	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	2.44e-05	0.000294	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—PPARA—prostate cancer	2.43e-05	0.000292	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	2.41e-05	0.00029	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—AKT1—prostate cancer	2.4e-05	0.000289	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—PPARA—prostate cancer	2.38e-05	0.000287	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GGT1—prostate cancer	2.36e-05	0.000284	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.36e-05	0.000284	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.34e-05	0.000282	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—PPARA—prostate cancer	2.33e-05	0.00028	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—NCOA1—prostate cancer	2.33e-05	0.00028	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.32e-05	0.000279	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.29e-05	0.000276	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.29e-05	0.000275	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.26e-05	0.000272	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.21e-05	0.000266	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—COMT—prostate cancer	2.13e-05	0.000257	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.12e-05	0.000255	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.1e-05	0.000253	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	2.1e-05	0.000252	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.09e-05	0.000252	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	2e-05	0.00024	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.98e-05	0.000239	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTM1—prostate cancer	1.95e-05	0.000235	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.93e-05	0.000232	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	1.92e-05	0.000231	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.89e-05	0.000228	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.86e-05	0.000224	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	1.85e-05	0.000222	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.85e-05	0.000222	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HAO1—prostate cancer	1.82e-05	0.00022	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.82e-05	0.000219	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.81e-05	0.000218	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.59e-05	0.000191	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CBR1—prostate cancer	1.49e-05	0.000179	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CSAD—prostate cancer	1.49e-05	0.000179	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ADI1—prostate cancer	1.49e-05	0.000179	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GRHL1—prostate cancer	1.49e-05	0.000179	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PSAT1—prostate cancer	1.49e-05	0.000179	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TST—prostate cancer	1.49e-05	0.000179	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CKMT2—prostate cancer	1.38e-05	0.000166	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.38e-05	0.000166	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.38e-05	0.000166	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GRHPR—prostate cancer	1.38e-05	0.000166	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PGAM2—prostate cancer	1.3e-05	0.000156	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AOX1—prostate cancer	1.3e-05	0.000156	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NAGLU—prostate cancer	1.3e-05	0.000156	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.3e-05	0.000156	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.3e-05	0.000156	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—RFK—prostate cancer	1.3e-05	0.000156	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTM3—prostate cancer	1.3e-05	0.000156	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AMACR—prostate cancer	1.23e-05	0.000148	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.23e-05	0.000148	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NAT1—prostate cancer	1.23e-05	0.000148	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—DEGS1—prostate cancer	1.23e-05	0.000148	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.23e-05	0.000148	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.18e-05	0.000141	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HPGD—prostate cancer	1.05e-05	0.000126	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.05e-05	0.000126	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TNFRSF21—prostate cancer	9.85e-06	0.000119	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP7B1—prostate cancer	9.58e-06	0.000115	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTAP—prostate cancer	9.58e-06	0.000115	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SULT1E1—prostate cancer	9.34e-06	0.000112	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SRD5A1—prostate cancer	9.34e-06	0.000112	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HSD17B3—prostate cancer	8.91e-06	0.000107	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ACSL4—prostate cancer	8.91e-06	0.000107	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ARG2—prostate cancer	8.54e-06	0.000103	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PHGDH—prostate cancer	8.54e-06	0.000103	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UMPS—prostate cancer	8.54e-06	0.000103	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—LDHB—prostate cancer	8.38e-06	0.000101	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP3A5—prostate cancer	8.22e-06	9.89e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PDHA1—prostate cancer	7.94e-06	9.56e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UCP3—prostate cancer	7.94e-06	9.56e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TCN2—prostate cancer	7.94e-06	9.56e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA3—prostate cancer	7.94e-06	9.56e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC22A3—prostate cancer	7.57e-06	9.12e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HSD3B1—prostate cancer	7.57e-06	9.12e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA4—prostate cancer	7.26e-06	8.74e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TBXAS1—prostate cancer	7.26e-06	8.74e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA2—prostate cancer	7.08e-06	8.52e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCG5—prostate cancer	6.99e-06	8.41e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SULT1A1—prostate cancer	6.99e-06	8.41e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA1—prostate cancer	6.83e-06	8.22e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTO1—prostate cancer	6.75e-06	8.13e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HSD3B2—prostate cancer	6.75e-06	8.13e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NAT2—prostate cancer	6.75e-06	8.13e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PLCB2—prostate cancer	6.47e-06	7.79e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—LRP2—prostate cancer	6.47e-06	7.79e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2C18—prostate cancer	6.47e-06	7.79e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—P4HB—prostate cancer	6.35e-06	7.64e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC22A1—prostate cancer	6.17e-06	7.43e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SULT2A1—prostate cancer	6.02e-06	7.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MED12—prostate cancer	5.92e-06	7.12e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GNG5—prostate cancer	5.87e-06	7.07e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOA3—prostate cancer	5.66e-06	6.81e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HPGDS—prostate cancer	5.4e-06	6.5e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.36e-06	6.46e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTT1—prostate cancer	5.23e-06	6.3e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ACHE—prostate cancer	5.23e-06	6.3e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.17e-06	6.23e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKR1C3—prostate cancer	5.03e-06	6.06e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PRKACB—prostate cancer	5.01e-06	6.03e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.96e-06	5.96e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOA2—prostate cancer	4.72e-06	5.68e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.5e-06	5.42e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.4e-06	5.3e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NQO1—prostate cancer	4.35e-06	5.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TH—prostate cancer	4.29e-06	5.16e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.17e-06	5.02e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GGT1—prostate cancer	4.04e-06	4.86e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOA1—prostate cancer	3.98e-06	4.79e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.92e-06	4.72e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—RXRA—prostate cancer	3.78e-06	4.56e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—COMT—prostate cancer	3.65e-06	4.39e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTP1—prostate cancer	3.63e-06	4.37e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ITPR1—prostate cancer	3.57e-06	4.3e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TYMS—prostate cancer	3.37e-06	4.06e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTM1—prostate cancer	3.33e-06	4.01e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—LPL—prostate cancer	3.27e-06	3.94e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.16e-06	3.8e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ERCC2—prostate cancer	3.14e-06	3.77e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTHFR—prostate cancer	2.95e-06	3.55e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PPARA—prostate cancer	2.89e-06	3.48e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CAV1—prostate cancer	2.72e-06	3.27e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.48e-06	2.98e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—INS—prostate cancer	2.34e-06	2.82e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CREBBP—prostate cancer	2.3e-06	2.76e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.18e-06	2.62e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NOS3—prostate cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.9e-06	2.28e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS2—prostate cancer	1.88e-06	2.26e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTEN—prostate cancer	1.64e-06	1.97e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—EP300—prostate cancer	1.56e-06	1.88e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.16e-06	1.39e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKT1—prostate cancer	9.45e-07	1.14e-05	CbGpPWpGaD
